Glenmark reports positive data of Favipiravir in Covid-19 PMS study
Interim results from 503 subjects showed two-third of participants achieved clinical cure on day seven.
mCureX and Samyang sign MoU for mRNA vaccine development
mCureX signs MoU with Samyang Holdings for a Covid-19 vaccine and with GC Pharma for...
Serum Institute obtains DCGI nod to produce Sputnik V vaccine in India
Serum Institute is the sixth company in India to sign an agreement with the RDIF...
AnHeart and Innovent enter taletrectinib licensing deal in Greater China
AnHeart and Innovent have entered an exclusive licence agreement to co-develop and market drug candidate...
Samsung Biologics to manufacture mRNA vaccine DS at Songdo plant
Samsung Biologics will add mRNA vaccine manufacturing services in Songdo, South Korea, to enhance its...
Prestige Biopharma’s New Vaccine Production Centre, Osong, South Korea
Prestige Biopharma (PBP), a Singapore-based biopharmaceutical company, is building a global-scale vaccine manufacturing centre in...
Cipla to market Roche’s Covid-19 antibody cocktail in India
Cipla said that the first batch of Roche’s antibody cocktail, Casirivimab and Imdevimab, is now...
QIMR Berghofer researchers create drugs for Covid-19
QIMR Berghofer Medical Research Institute scientists create two peptide-based drugs for Covid-19 prevention and treatment.
Japan authorises AstraZeneca and Moderna’s Covid-19 vaccines
Japan’s MHLW authorises Covid-19 vaccines of AstraZeneca and Moderna for emergency use in the country.
Eskayef Bangladesh, Dhaka, Tongi
Eskayef Bangladesh, also known as Eskayef Pharmaceuticals or SK+F, is one of the largest and...
